T. Rowe Price Associates
TVTY

T. Rowe Price Associates’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

T. Rowe Price Associates’s Portfolio TVTY Stock Details TVTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,693
Closed -$827K – 3030
2022
Q1 		$827K Sell
25,693
-1,667
-6% -$45.1K ﹤0.01% 2095
2021
Q4 		$723K Sell
27,360
-800
-3% -$20.3K ﹤0.01% 2196
2021
Q3 		$649K Hold
28,160
– – ﹤0.01% 2249
2021
Q2 		$741K Sell
28,160
-6,685
-19% -$168K ﹤0.01% 2200
2021
Q1 		$778K Buy
34,845
+3,498
+11% +$80.2K ﹤0.01% 2170
2020
Q4 		$614K Sell
31,347
-12,410
-28% -$206K ﹤0.01% 2161
2020
Q3 		$613K Buy
43,757
+2,200
+5% +$31.8K ﹤0.01% 2011
2020
Q2 		$471K Sell
41,557
-113
-0.3% -$1.03K ﹤0.01% 2070
2020
Q1 		$262K Buy
41,670
+14,944
+56% +$241K ﹤0.01% 2239
2019
Q4 		$544K Buy
26,726
+9,633
+56% +$180K ﹤0.01% 2125
2019
Q3 		$284K Buy
17,093
+228
+1% +$3.94K ﹤0.01% 2308
2019
Q2 		$277K Buy
16,865
+105
+0.6% +$2.03K ﹤0.01% 2326
2019
Q1 		$294K Buy
16,760
+4,120
+33% +$87.7K ﹤0.01% 2303
2018
Q4 		$314K Buy
12,640
+75
+0.6% +$2.49K ﹤0.01% 2266
2018
Q3 		$404K Buy
12,565
+237
+2% +$8.08K ﹤0.01% 2238
2018
Q2 		$434K Buy
+12,328
New +$455K ﹤0.01% 2201
2018
Q1 		– Sell
-306,513
Closed -$11.2M – 2601
2017
Q4 		$11.2M Sell
306,513
-5,390
-2% -$204K ﹤0.01% 1319
2017
Q3 		$12.7M Buy
+311,903
New +$12.1M ﹤0.01% 1298
2015
Q4 		– Sell
-491,960
Closed -$5.47M – 2550
2015
Q3 		$5.47M Sell
491,960
-510
-0.1% -$6.23K ﹤0.01% 1423
2015
Q2 		$5.9M Sell
492,470
-39,410
-7% -$654K ﹤0.01% 1449
2015
Q1 		$10.5M Sell
531,880
-69,950
-12% -$1.46M ﹤0.01% 1329
2014
Q4 		$12M Buy
601,830
+5,700
+1% +$93.1K ﹤0.01% 1271
2014
Q3 		$9.55M Buy
596,130
+900
+0.2% +$15.3K ﹤0.01% 1325
2014
Q2 		$10.4M Sell
595,230
-7,660
-1% -$132K ﹤0.01% 1305
2014
Q1 		$10.3M Sell
602,890
-500
-0.1% -$7.7K ﹤0.01% 1290
2013
Q4 		$9.26M Sell
603,390
-710
-0.1% -$10.1K ﹤0.01% 1303
2013
Q3 		$11.2M Sell
604,100
-3,000
-0.5% -$54.2K ﹤0.01% 1239
2013
Q2 		$10.6M Buy
+607,100
New +$8.37M ﹤0.01% 1234

Other funds holding TVTY

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
PP
Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

T. Rowe Price Associates's TVTY Position: Q2 2022 in Review

T. Rowe Price Associates sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 25,693 shares — an estimated $827K sold.

T. Rowe Price Associates first reported a position in TVTY in Q2 2013 and held it in 28 quarters. The position peaked at $12.7M in Q3 2017. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • T. Rowe Price Associates reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 25,693 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $827K.
  • T. Rowe Price Associates first reported a position in Tivity Health, Inc. Common Stock in Q2 2013 and held it in 28 quarters.
  • T. Rowe Price Associates's Tivity Health, Inc. Common Stock position peaked at $12.7M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.